COSENTYX sol inj 300 mg/2ml ser pré
7680652250034
CH-65225
L04AC10
07.15.0.
Reimbursement limitations:
COSENTYX.01
Psoriasis en plaques sévère
Cosentyx est indiqué pour le traitement des patients adultes et pédiatriques …
1 / 3
google
Details
- Product number
- 6522502
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- secukinumabum 300.0 mg, trehalosum dihydricum, histidinum, histidini hydrochloridum monohydricum, methioninum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 2 ml.
Articles (1)
Cosentyx 300 mg / 2 ml, Injektionslösung in einer Fertigspritze
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HIMDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HIMDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1185.10
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2022
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 65225
- Drug name
- Cosentyx, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- L04AC10
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 20/02/2015
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- COSENTYX sol inj 300 mg/2ml ser pré
- Description (DE)
- COSENTYX Inj Lös 300 mg/2ml Fertspr
- Market launch
- 03/02/2022
- Narcotic (BTM)
- No